Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PF-249 (PF-06685249) is a β1-selective AMPK with an EC50 of 12 nM for AMPK α1β1γ1 and can be used in studies about diabetic nephropathy.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 87.00 | |
2 mg | In stock | $ 127.00 | |
5 mg | In stock | $ 213.00 | |
10 mg | In stock | $ 313.00 | |
25 mg | In stock | $ 533.00 | |
50 mg | In stock | $ 768.00 | |
100 mg | In stock | $ 1,080.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 223.00 |
Description | PF-249 (PF-06685249) is a β1-selective AMPK with an EC50 of 12 nM for AMPK α1β1γ1 and can be used in studies about diabetic nephropathy. |
Targets&IC50 | AMPK α1β1γ1:12 nM (EC50) |
Synonyms | PF-06685249, PF 06685249, PF06685249 |
Molecular Weight | 345.78 |
Formula | C17H16ClN3O3 |
CAS No. | 1467059-70-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 90 mg/mL (260.3 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PF-249 1467059-70-6 Chromatin/Epigenetic PI3K/Akt/mTOR signaling AMPK PF-06685249 PF 06685249 PF249 PF06685249 PF 249 inhibitor inhibit